TRPM8 and esophageal cancer: Our results showed that blocking the activity of calcineurin inhibited the nuclear translocation of NFATc3 and PD-L1 expression in esophageal cancer cells, which inferred a contributing role of TRPM8-calcineurin-NFATc3 in the expression of PD-L1.